Infection Control Committee, Siyami Ersek Thoracic and Cardiovascular Surgery Hospital, Istanbul, Turkey.
J Hosp Infect. 2013 Nov;85(3):206-12. doi: 10.1016/j.jhin.2013.07.010. Epub 2013 Sep 12.
Since sternal surgical site infections (SSIs) can be life-threatening, every effort should be made to reduce their rate of occurrence.
To measure the rate of sternal SSIs after open heart surgery and to define the efficacy of infection control interventions in reducing this rate.
Surveillance of sternal SSIs was carried out prospectively for adult patients who underwent sternotomy between 2005 and 2012. Infection control interventions that were undertaken during the study period at different time intervals were prophylaxis with cefazolin or vancomycin, surveillance of sternal SSIs and feedback, preoperative nasal Staphylococcus aureus screening and decolonization with mupirocin, isolation of patients infected with or colonized by meticillin-resistant S. aureus, appropriate management of perioperative blood glucose level and chlorhexidine/alcohol usage for skin antisepsis.
There were 479 sternal SSIs in 18,460 patients during the study period (2.59%). The most frequent causes of sternal SSIs were coagulase-negative staphylococci (CoNS) (36%) and S. aureus (31%). Infection control interventions reduced the rate of sternal SSIs from 3.63% in 2005 to 1.65% in 2012 (P < 0.0001).
Our study shows that the rate of sternal SSIs can be decreased with proper infection control interventions. However, the interventions that were undertaken were effective only in reducing the rate of sternal SSIs caused by S. aureus. It is time to find interventions to control sternal SSIs caused by CoNS, the pathogen responsible for most sternal SSIs in hospitals where S. aureus SSIs are successfully controlled.
由于胸骨外科部位感染(SSI)可能危及生命,因此应尽一切努力降低其发生率。
测量体外循环心脏手术后胸骨 SSI 的发生率,并确定感染控制干预措施降低该发生率的效果。
对 2005 年至 2012 年间行胸骨切开术的成年患者进行前瞻性监测胸骨 SSI。在研究期间,不同时间间隔采取了头孢唑啉或万古霉素预防、监测胸骨 SSI 并提供反馈、术前鼻腔金黄色葡萄球菌筛查和莫匹罗星去定植、对耐甲氧西林金黄色葡萄球菌感染或定植的患者进行隔离、适当管理围手术期血糖水平以及使用洗必泰/酒精进行皮肤消毒等感染控制干预措施。
在研究期间,有 479 例胸骨 SSI 发生于 18460 例患者中(2.59%)。胸骨 SSI 最常见的病原体为凝固酶阴性葡萄球菌(CoNS)(36%)和金黄色葡萄球菌(31%)。感染控制干预措施将胸骨 SSI 发生率从 2005 年的 3.63%降低至 2012 年的 1.65%(P<0.0001)。
本研究表明,正确的感染控制干预措施可降低胸骨 SSI 的发生率。然而,所采取的干预措施仅对降低金黄色葡萄球菌引起的胸骨 SSI 有效。现在是时候寻找控制金黄色葡萄球菌 SSI 成功控制的医院中 CoNS 引起的胸骨 SSI 的干预措施了。